Abstract
Tyr-3-Octreotide is a synthetic derivative of somatostatin and a somatostatin-receptor analogue. The iodine-123-labelled compound localizes somatostatin-receptor-positive tumours. In this paper two patients are reported in whom somatostatin receptors were demonstrated in vitro. In a 60-year-old female with an islet cell carcinoma of the pancreas, multiple liver metastases and previously unrecognized bone metastases in the right acetabulum could be diagnosed as the reason for a persistent hypoglycaemia. In a 60-year-old male an islet cell carcinoma of the pancreas was localized with123I-Tyr-3-octreotide. The somatostatin receptors were demonstrated in vitro and the tumour was successfully treated with somatostatin. These studies demonstrate that123I-Tyr-3-octreotide offers the possibility of localizing somatostatin-receptor-positive tumours and their metastases. Moreover the method makes it possible to determine the receptor status of a tumour in vivo.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bakker WH, Krenning EP, Breeman WA, Koper JW, Kooij PP, Reubi JC, Klijn JG, Visser TJ, Docter R, Lamberts SW (1990) Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity and in vivo application in animals. J Nucl Med 31:1501–1509
Bloom SR, Polak JM (1980) Glucagonomas, VIPomas and somatostatomas. Clin Endocrinol Metab 9:285–297
Junginger T, Böttger T, Beyer J, Thelen M (1990) Der organische Hyperinsulinismus-Diagnostik und Therapie. Dtsch Ärtzebl 87:B2418-B2423
Krenning EP, Bakker WH, Breeman WAP, Koper JW, Kooij PPM, Ausema L, Lameris JS, Reubi JC, Lamberts SWJ (1989) Localization of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1:242–244
Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP (1990a) Treatment with sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs. Metabolism 39:152–155
Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP (1990b) Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 323:1246–1249
Lamberts SWJ, Hofland LJ, Koetsfled van PM, Reubi JC, Bruining HA, Bakker WH, Krenning EP (1990c) Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumours: consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab 71:566–574
Reubi J-C, Hacki WH, Lamberts SWJ (1987) Hormone producing gastrointestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab 65:1127–1134
Reubi JC, Kvols L, Krenning E, Lamberts SWJ (1990) Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 39:78–81
Stefani P, Carboni M, Patrassi N, Basoli A (1974) Beta-islet tumors of the pancreas: results on 1067 cases. Surgery 75:597–609
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Becker, W., Marienhagen, J., Scheubel, R. et al. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas. Eur J Nucl Med 18, 924–927 (1991). https://doi.org/10.1007/BF02258458
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02258458